Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» PTC Therapeutics
PTC Therapeutics
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
TheStreet.com
Thu, 03/9/17 - 11:25 am
FDA
drug approvals
Alkermes
ALKS-5461
CytRx
aldoxorubicin
Dynavax Technologies
HEPLISAV-B
Intra-Cellular Therapies
ITI-007
Novan
SB204
Portola Pharmaceuticals
betrixaban
PTC Therapeutics
ataluren
Rigel Pharmaceuticals
fostamatinib
TG Therapeutics
ublituximab
Bad News Biotechs: What's Next for Juno and PTC Therapeutics?
Motley Fool
Mon, 03/6/17 - 09:40 am
Juno Therapeutics
PTC Therapeutics
CAR-T
Celgene
cystic fibrosis
Translarna
PTC shares plunge anew after FDA slaps down Duchenne drug for a second time
Endpoints
Mon, 10/17/16 - 11:46 pm
PTC Therapeutics
FDA
Duchenne Muscular Dystrophy
Translarna
Sarepta: The Competition Is At The Gate
Seeking Alpha
Fri, 08/12/16 - 09:53 am
Sarepta Therapeutics
eteplirsen
Biomarin
Summit Therapeutics
PTC Therapeutics
Duchenne Muscular Dystrophy
Duchenne drug rejected in US is available in England
Pharma Times
Fri, 07/8/16 - 10:16 am
Duchenne Muscular Dystrophy
England
PTC Therapeutics
Translarna
Biotech's Top 5 Stock Winners, And Losers, In Q1 2016
Forbes
Thu, 03/31/16 - 09:49 pm
biotech
PTC Therapeutics
Celldex Therapeutics
Biocryst
Puma Biotechnology
Portola Pharmaceuticals
MedicNova
BioTie Therapies
Editas Medicine
AveXis
Inovio
4 Biopharma and Pharmaceutical Stocks With Game-Changing Catalysts Coming
24/7 Wall St
Fri, 11/20/15 - 11:02 am
Pfizer
Sarepta Therapeutics
PTC Therapeutics
Amag Pharmaceuticals
PTC Therapeutics Drug Doesn't Meet Goal in Duchenne Trial
Bloomberg
Fri, 10/16/15 - 06:59 am
PTC Therapeutics
Duchenne Muscular Dystrophy
clinical trials
Translarna
FDA finally responds to demand for Duchenne Muscular Dystrophy guidance
BioPharma Dive
Wed, 06/10/15 - 10:58 am
FDA
Duchenne Muscular Dystrophy
Saretpa
PTC Therapeutics
Pfizer
Biomarin
Roche presses pause on PTC's SMA drug over a safety scare
Fierce Biotech
Tue, 05/5/15 - 11:06 am
Roche
PTC Therapeutics
spinal muscular atrophy
RG7800
It's A Big Weekend For Biotech
Yahoo/Benzinga
Sat, 04/18/15 - 11:55 am
biotech
Biogen
BIIB037
RG7800
PTC Therapeutics
Alnylam
CAR-T
Merck
Bristol-Myers Squibb
Novartis
Juno Therapeutics
Bellicum
This biotech doubled in value last year
CNBC
Mon, 01/19/15 - 10:08 am
PTC Therapeutics
Shire
Shire’s Next Targets Could Be on This List: Real M&A
Bloomberg
Wed, 01/14/15 - 10:00 am
Shire
M&A
PTC Therapeutics
SynaGeva BioPharma
Retrophin
Ultragenyx
Vertex Pharmaceuticals
Biomarin
The Best-Performing Biotechnology Stocks Of 2014
Forbes
Thu, 01/1/15 - 02:32 pm
biotech
Avanir
OvaScience
Agios
Bluebird Bio
Receptos
Prosensa
Pernix
Achillion
Amicus Therapeutics
CytoSorbents
PTC Therapeutics
3 Drugmakers Facing a Pivotal 2015
Motley Fool
Mon, 12/22/14 - 01:12 pm
PTC Therapeutics
Translarna
GW Pharma
Isis Pharmaceuticals
The 5 Best Biotech Stocks in 2014...so far
Motley Fool
Fri, 09/26/14 - 11:42 am
biotech
Intercept Pharmaceuticals
Achillion
Puma Biotechnology
PTC Therapeutics
Receptos
Most popular news headlines for Thursday, August 7 2014
CP Wire
Fri, 08/8/14 - 08:14 am
Allergan
M&A
Valeant Pharmaceuticals
tax inversions
PTC Therapeutics
Duchenne Muscular Dystrophy
ebola virus
Tekmira Pharmaceuticals
Most popular news headlines for Thursday, August 7 2014
Fri, 08/8/14 - 08:12 am
Allergan
M&A
Valeant Pharmaceuticals
tax inversions
PTC Therapeutics
Duchenne Muscular Dystrophy
ebola virus
Tekmira Pharmaceuticals
Why a bigger deal hasn't been made of the world's first approval of a Duchenne drug
Bizjournals.com
Thu, 08/7/14 - 09:45 am
Duchenne Muscular Dystrophy
drug approvals
PTC Therapeutics
Translarna
What You Need to Know About PTC Therapeutics' Promising DMD Drug
Motley Fool
Thu, 06/5/14 - 11:19 am
Duchenne Muscular Dystrophy
PTC Therapeutics
eteplirsen
Pages
« first
‹ previous
1
2
3
4
next ›
last »